A Study of Preferences of Participants and Oncologists for the Characteristics of the Treatment for Renal Cell Carcinoma (RCC) In Spain And Portugal
NCT05168436 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 105
Last updated 2021-12-23
Summary
The purpose of this observational study is to determine patients' and professionals' preferences for the characteristics (attributes) of the treatment for Renal cell carcinoma (RCC) in Spain and Portugal.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-08-05
- Primary Completion
- 2020-07-13
- Completion
- 2020-07-13
Countries
- Spain
Study Locations
More Related Trials
-
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
NCT02128906 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy Study in Patients With Local Advanced Larynx/Hypolarynx Carcinoma Treated With TPF Induction Chemotherapy Followed by Hyperfractionated Radiotherapy With Cetuximab
NCT00941135 ·Status: TERMINATED ·Phase: PHASE2
-
Real-World Evidence and Treatment Patterns: Head and Neck Cancer
NCT03157674 ·Status: COMPLETED
-
Predicting Toxicity in Elderly Patients With Head and Neck Cancer
NCT06344208 ·Status: RECRUITING
-
Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma
NCT02984410 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Non-comparative Study of Treatment With Induction Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation or Definitive Chemoradiation in Invasive Locally Advanced Carcinomas of Uterine Cervix.
NCT01973101 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of the Contribution of Mutant p53/YAP Proteins to Therapy Resistance in Recurrent Head and Neck Cancer
NCT06791941 ·Status: RECRUITING
-
Erlotinib,Radiation and Cisplatin in Patients With Complete Resected Squamous Cell Carcinoma of the Head and Neck
NCT00442455 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease
NCT03101995 ·Status: RECRUITING ·Phase: PHASE2
-
SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)
NCT02543476 ·Status: COMPLETED
-
Identification of Predictive Factors for the Response to Anti-Programmed Cell Death Protein 1 (PD1) Immunotherapy in Head and Neck Squamous Cell Carcinoma
NCT05328024 ·Status: RECRUITING
-
A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers
NCT01936376 ·Status: UNKNOWN
-
Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck
NCT02474368 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers
NCT05483374 ·Status: RECRUITING
-
Comparing the Efficacy of Surgery Staging and Image Staging of Locally Advanced Cervical Cancer
NCT05378087 ·Status: RECRUITING ·Phase: NA
-
The Clinical Study of the Poorly Differentiated Head and Neck Squamous Cell Carcinoma
NCT02916368 ·Status: UNKNOWN
-
Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer
NCT00868491 ·Status: COMPLETED ·Phase: PHASE2
-
Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
NCT00705016 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase II Study to Evaluate the Efficacy and Safety of Salvage Preoperative PD-1 Inhibitor Combined with Chemotherapy Neoadjuvant Therapy in Recurrent and Metastatic LPSCC/HPSCC
NCT06793761 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer
NCT05189028 ·Status: RECRUITING ·Phase: PHASE3
-
Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)
NCT01312350 ·Status: COMPLETED ·Phase: PHASE2
-
An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Patients With Head and Neck Cancer Receiving REGN2810 (Anti-PD-1)
NCT03198130 ·Status: COMPLETED ·Phase: PHASE1
-
International Prospective Multicentre Study That Evaluate the Sentinel Lymph Node Detection Rate in Patients With First Local Recurrent Scamous Cell Carcinoma of the Vulva.
NCT07023601 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Induction Modified TPF Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT05527782 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study in Head and Neck Cancer
NCT01081041 ·Status: COMPLETED ·Phase: PHASE2